Clinops

And that's all for today's ACT Brief.

Join us again next week for more updates shaping ClinOps and drug development.

Thanks for listening, and have a great weekend.

And that's all for today's ACT Brief.

Join us again tomorrow for more updates shaping ClinOps and drug development.

And that's all for today's ACT Brief.

Join us again tomorrow for more updates shaping ClinOps and drug development.

And that's all for today's ACT Brief.

Join us again tomorrow for more updates shaping ClinOps and drug development.

And that's all for today's ACT Brief.

Join us again next week for more updates shaping ClinOps and drug development.

And that's all for today's ACT Brief.

Join us again tomorrow for more updates shaping ClinOps and drug development.

So a big part of the job going into that meeting is to prep leadership for this call, for this meeting with this important KOL.

And then you want to be comfortable yourself, right? With the agenda, with the flow of that agenda, you're going to drive it, right? A solid MSL is going to go in and you're going to drive that independent of whether you have the CEO or the VP of ClinOps, VP of medical affairs.

So I just remember all the time and effort in searching this website, that website, putting it all together into a fancy PowerPoint.

This is now taking, I guess, I mean, seconds to minutes, right, to do this.

And that's all for today's ACT Brief.

Join us again next time for more updates shaping ClinOps and drug development.

And that's all for today's ACT Brief.

Join us again next week for more updates shaping ClinOps and drug development.

He focuses on situational design and the elicitation of expert knowledge that clinicians and medical affairs teams rarely put into words and experience sampling as a means of capturing friction in real time.

Jason recently co-authored a column with Kelly and me that offered a very critical perspective into the complexity of how we think and how we behave and introduced a powerful tool that can help ClinOps community members understand the real-world daily burden and friction that ClinOps professionals experience.

We will revisit the concept of experience sampling in an upcoming episode of the podcast.

But first, we'd like to step back and take a broader look at how the complexity of cognitive and behavioral science impacts trial execution and to explore how we can use this science to minimize trial burden and optimize trial success.